{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:09:39Z","timestamp":1768396179177,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.semarthrit.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T15:31:31Z","timestamp":1499700691000},"page":"565-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN)"],"prefix":"10.1016","volume":"47","author":[{"given":"L\u00e9a","family":"Savey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9rome","family":"Bellanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Sauvanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Pouget-Abadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Sogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Emmerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2017.07.001_bib1","first-page":"1014","article-title":"Pancreatitis in systemic lupus erythematosus: still in search of a mechanism","volume":"19","author":"Petri","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0149-7944(00)00392-5","article-title":"The incidence of intraductal papillary mucinous tumors of the pancreas(1)","volume":"57","author":"McDonald","year":"2000","journal-title":"Curr Surg"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000090023","article-title":"International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas","volume":"6","author":"Tanaka","year":"2006","journal-title":"Pancreatology"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0002-9610(00)00376-7","article-title":"Clinical presentation of mucin-secreting tumors of the pancreas","volume":"179","author":"Tibayan","year":"2000","journal-title":"Am J Surg"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/SLA.0b013e3182383137","article-title":"Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas","volume":"254","author":"Pedrazzoli","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.autrev.2006.06.012","article-title":"The catastrophic antiphospholipid (Asherson\u2032s) syndrome and malignancies","volume":"6","author":"Miesbach","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10067-007-0634-x","article-title":"The role of malignancies in patients with catastrophic anti-phospholipid (Asherson\u2032s) syndrome","volume":"26","author":"Miesbach","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12016-007-0003-1","article-title":"Antiphospholipid syndrome and cancer","volume":"32","author":"Reinstein","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the CAPS Registry","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJM198404053101407","article-title":"Current concepts. Primary sclerosing cholangitis","volume":"310","author":"LaRusso","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0002-9343(86)90412-2","article-title":"Primary sclerosing cholangitis in the presence of a lupus anticoagulant","volume":"81","author":"Kirby","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2133.1994.tb02938.x","article-title":"Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases","volume":"130","author":"Stevens","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.semarthrit.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0025-6196(11)63706-3","article-title":"Ischemic cholangitis","volume":"73","author":"Batts","year":"1998","journal-title":"Mayo Clin Proc"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217303050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217303050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T10:46:08Z","timestamp":1530269168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217303050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0049017217303050"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.07.001","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catastrophic antiphospholipid syndrome (CAPS)-induced ischemic pancreatic ducts injury mimicking intraductal papillary mucinous neoplasm (IPMN)","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}